Cargando…
Clinical and Histopathological Factors Associated with the Tumoral Expression of TGF-β1, MED15, CD16, and CD57 in Oral Squamous Cell Carcinoma
INTRODUCTION: Factors associated with the expression of oral squamous cell carcinoma (OSCC) biomarkers “CD16, CD57, TGF-β1, and MED15” are not assessed, except in few controversial studies of some of these biomarkers. This study aimed to highlight factors that can correlate with tumoral overexpressi...
Autores principales: | Elahi, Maryam, Rakhshan, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633212/ https://www.ncbi.nlm.nih.gov/pubmed/36340330 http://dx.doi.org/10.1155/2022/3145117 |
Ejemplares similares
-
MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma
por: Elahi, Maryam, et al.
Publicado: (2020) -
Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma
por: Zargaran, Massoumeh
Publicado: (2020) -
Functional Studies of the Yeast Med5, Med15 and Med16 Mediator Tail Subunits
por: Larsson, Miriam, et al.
Publicado: (2013) -
Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study
por: Agarwal, Rashmi, et al.
Publicado: (2016) -
CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
por: Shakib, Pouyan Amini, et al.
Publicado: (2015)